Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha

J Leukoc Biol. 1987 Mar;41(3):196-204. doi: 10.1002/jlb.41.3.196.

Abstract

The interaction of highly purified recombinant human tumor necrosis factor-alpha (rTNF-alpha) with human polymorphonuclear neutrophils (PMNs) was investigated. Binding of 125I-rTNF-alpha to PMN reached maximum levels in 30 min at 37 degrees C and in 2 h at 4 degrees C. Scatchard analysis of competitive binding data indicated approximately 6000 receptor sites per cell and a Kd of 1.37 nM. Binding data at 37 degrees C indicated a rapid internalization of rTNF-alpha. Following this receptor-mediated interaction, recombinant TNF-alpha was found to inhibit the migration of PMNs under agarose and to enhance PMN production of superoxide anion (O-2) in a dose-dependent manner. Furthermore, rTNF-alpha-activated PMNs caused a marked disruption of human umbilical-vein-derived endothelial cell monolayers and caused inhibition of their proliferative activities. These data substantiate the role of TNF-alpha as an activator of PMN functions and indicate that PMN/TNF-alpha/endothelial cell interactions may play a major role in inflammatory reactions.

MeSH terms

  • Binding, Competitive
  • Cell Division
  • Cell Movement
  • Endothelium / physiology
  • Glycoproteins / metabolism*
  • Humans
  • Interferon-gamma / metabolism
  • Lymphocytes / metabolism
  • Monocytes / metabolism
  • Neutrophils / physiology*
  • Receptors, Cell Surface / metabolism*
  • Receptors, Tumor Necrosis Factor
  • Recombinant Proteins / metabolism
  • Superoxides / metabolism
  • Tumor Necrosis Factor-alpha

Substances

  • Glycoproteins
  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Superoxides
  • Interferon-gamma